Hedonia
Relieving Anxiety and Depression Symptoms
Company Overview
Snapshot
Founded in July 2021 by Samuel Keret, Adi Pundak-Mintz, and Moshe Bar, Hedonia operated with 11–50 employees. The company raised $5 million across two funding rounds from eight investors. In March 2026, Hedonia ceased to operate.
Business overview
Hedonia is a Health Tech & Life Sciences company focused on digital therapeutics for mental health. The company develops a mobile gaming solution, Mood Bloom, that utilizes Facilitating Thought Progression (FTP), a science-based approach from cognitive neuroscience researchers, to alleviate symptoms of depression and anxiety. Hedonia's product is designed to fit modern lifestyles, requiring only a few minutes daily to deliver results, and can be used alongside other psychological treatments like CBT. It serves patients and providers within the broader healthcare market.
Strategic signal
In March 2026, Hedonia ceased operations. This event signals a significant challenge in the digital therapeutics market, highlighting the difficulties even clinically validated solutions can face in achieving sustainable business models or market traction. For investors, it underscores the importance of evaluating not only clinical efficacy but also market viability and operational resilience in early-stage health tech ventures.
Log in to access full profile ›Company Intelligence Q&A
- What is Hedonia's core product?
- Hedonia's core product is Mood Bloom, a mobile gaming application designed to relieve symptoms of anxiety and depression using Facilitating Thought Progression (FTP, a science-based solution).
- When was Hedonia founded and by whom?
- Hedonia was founded in July 2021 by Samuel Keret, Adi Pundak-Mintz, and Moshe Bar.
- What was the most recent significant corporate event for Hedonia?
- In March 2026, Hedonia ceased to operate, marking the end of its business activities.
- What was the total capital raised by Hedonia?
- Hedonia raised a total of $5 million across two funding rounds.
- What was a key finding from Hedonia's clinical trials?
- In December 2023, Hedonia announced that its novel approach demonstrated dramatic improvement in depression scores during a robust clinical trial.